Frequently Asked Questions
The market is segmented based on , By Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Transfusion Centers) - Industry Trends and Forecast to 2030.
.
The Global Leukapheresis Market size was valued at USD 33949.12 USD Million in 2023.
The Global Leukapheresis Market is projected to grow at a CAGR of 8.16% during the forecast period of 2024 to 2030.
The major players operating in the market include Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, TERUMO BCT , STEMCELL Technologies , Fresenius SE & Co. KGaA, HemaCare, B. Braun Melsungen AG, Caltag Medsystems Limited, AllCells, StemExpress, Precision for Medicine, Lonza, BioIVT, Lmb Technologie GmbH, Grifols, S.A, Kaneka Pharma Europe NV.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.
